February 2024
16 May 2024
The global gene synthesis market size surpassed USD 2.60 billion in 2023 and is estimated to cross around USD 17.99 billion by 2032, poised to grow at a CAGR of 23.97% from 2023 to 2032. The increasingly favorable government initiatives regarding synthetic biology are attributed to driving the growth of the gene synthesis market.
The gene synthesis market is the artificial feature of DNA sequences, typically using automated DNA synthesis machines or chemical methods. It enables researchers to produce and design custom DNA molecules with specified sequences and allows the study of genetic engineering, protein expression, and gene function. Decided therapy in combination with chemotherapy and immunotherapy is expected to drive the market growth.
The increasing prevalence of various chronic diseases and genetic disorders is anticipated to enhance the market growth. In addition, increasing concerns about genetic disorders are considered to drive the adoption of the rate of subsequent treatment and gene synthesis, increasing emergence of various infectious diseases and growing government funding for research and development activities in the pharmaceutical industry is further anticipated to drive the growth of gene synthesis market during the forecast period.
Rising government and academic research institutes engaged in genetic and genomics engineering projects, which is fueling the market growth
Government and academic research institutes highly integrate gene synthesis services to complete fundamental science studies, genetic engineering, and genomics projects. Due to the growing capacity of the industry, more diverse end users are searching for gene synthesis solutions. Partnerships and collaboration activities are improving innovation offered for gene synthesis by contract research organizations, biotechnology companies, and academic institutions. These collaborative agreements are enhancing research and product development in various industries.
In addition, academic and government research organizations tailor these services for their genetic and genomics engineering projects. These are the major driving factors anticipated to enhance the growth of the gene synthesis market during the forecast period.
However, a lack of skilled professionals and data misuse may restrain the market's growth. The scarcity of industry professionals is one of the major factors hindering market growth. Misuse of gene synthesis in forensic research and other gene synthesis purposes may disturb the safety and security of data and may reduce gene synthesis’s market share.
In addition, factors such as technical limitations, tempting price reductions, fierce competition in the manufacturing process, and lack of knowledge of professionals can't improve and develop the gene synthesis process. These are the major hindering factors that may restrain the growth of the gene synthesis market.
| Report Coverage | Details |
| Market Revenue in 2023 | USD 2.60 Billion |
| Projected Forecast Revenue by 2032 | USD 17.99 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 23.97% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Recent Development by Twist Bioscience Corporation
Recent Development by Molecular Assemblies, Inc.
North America dominated the gene synthesis market in 2023. The increasing prevalence of chronic diseases and increasing investments in research and development activities by the market players are anticipated for market growth. The U.S. and Canada are the major emerging countries in North America. There are various market key players in the U.S., such as General Biosystems, Inc., Boster Biological Technology, Creative Biogene, Exonbio, Twist Bioscience, OriGene Technologies, Integrated DNA Technologies, Ansa Biotechnologies, Thermo Fisher Scientific Inc., Genescript, Synbio Technologies, Ginkgo Bioworks, and ProMab. These are the major companies that are expected to drive the growth of the gene synthesis market in North America.
Asia Pacific had the second-largest share of the market in 2023. The increasing number of gene therapies in developing countries and increasing demands from the healthcare sector in this region are expected to drive market growth. India, China, Japan, and South Korea are the major leading companies in the gene synthesis market in the Asia Pacific region.
In China, cutting-edge facilities offer global researchers top-quality plasmid DNA services, cloning, and gene synthesis. China’s worldwide occurrence enables efficient and quick access to their top-most services and helps researchers to focus on their goals with confidence. China is actively supporting its researcher's demand and improving innovation in the field of genetic synthesis sciences.
In India, a fast-expanding Bengaluru-based genomic company, Barcode Bioscience, has succeeded in developing artificial gene synthesis in its no-cost facility and has become the leading Biotech company to initiate end-to-end users at a commercial scale in India. Investments in research and development and infrastructure are expected to enhance the healthcare system in India.
The continuous rise in healthcare spending creates a lucrative opportunity for the growth of the gene synthesis sector. GCC Biotech, Synbio Technologies, Kaneka Eurogentec S.A., Merck KGaA, and Eurofins Scientific are the major key players and are anticipated to drive the growth of the gene synthesis market in the Asia Pacific region.
Expansion of synthetic biology and the rising need for custom-designed constructs
There is an increasing demand for custom-designed synthetic genes and DNA constructs due to the technological advancements in synthetic biology. This involves the development of agricultural improvements, sustainable bio-manufacturing processes, and novel therapeutics. Gene synthesis companies enable them to benefit from this rising need by offering advanced solutions to industries and researchers searching to leverage gene synthetic biology for problem-solving and innovation.
The scalability and flexibility of gene synthesis technologies help market players expand their companies and the landscape of synthetic biology. These are the major opportunities that are expected to enhance the growth of the gene synthesis market in the coming future.
By Method
By Service
By Application
By End Users
Buy this Research Report@ https://www.precedenceresearch.com/checkout/2278
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
February 2024
October 2023
July 2023
July 2022